Race, ethnicity, and prior colorectal screening test use in CONFIRM colonoscopy vs fecal immunochemical testing trial participants
Clicks: 24
ID: 326482
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
6.9
/100
24 views
23 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #33 of 53 articles by views in jnci cancer spectrum
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND: Colorectal cancer (CRC) outcomes vary by both race and ethnicity, and screening test use may contribute to this variation. We examined the association of race, ethnicity, and associated factors with CRC screening test use in a setting where financial barriers to screening are mitigated. METHODS: Survey information was gathered from US Veteran participants (N = 50,125) when enrolled into a randomized trial comparing screening colonoscopy to annual fecal immunochemical testing (FIT) in the prevention of CRC mortality. The primary exposures of interest were the participants' self-identified race and ethnicity, with adjustment for variables capturing access to care. Multivariable logistic regression, stratified by site and age, was used to assess the relationship between exposures of interest and prior use of any CRC screening test, prior colonoscopy, and prior fecal occult blood test (FOBT, including FIT) use. RESULTS: Screening test use was common (N = 28,330, 56.5%) with more Veterans reporting prior FOBT (N = 20,386, 40.7%) than prior colonoscopy (N = 12,671, 25.3%). In multivariable analysis, Black participants were more likely (odds ratio (OR), 1.06; 95% confidence interval (CI) 1.01-1.12) to have had any prior screening relative to White persons and this finding was driven by more frequent FOBT use relative to White persons (OR, 1.16; 95% CI 1.10-1.23). There was no association between Hispanic ethnicity (relative to White persons) on the primary outcomes. CONCLUSIONS: In this cohort, prior screening test use was common, with observed variation in overall test use by race, but not ethnicity. Further study of CRC screening test use in diverse populations are needed. CLINICALTRIALS.GOV ID: NCT#05612347.
| Reference Key |
openalex_W7204278458
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Douglas J. Robertson, Jason A. Dominitz, Alexander Beed, Kathy Boardman, Barbara J. Del Curto, Peter Guarino, Grant D. Huang, Thomas F Imperiale, Andrew Lacasse, Meaghan Larson, Samir Gupta, David Lieberman, Beata Planeta, Timothy J. O’Leary, Aasma Shaukat, Shanaz Sultan, Tassos C. Kyriakides, the CONFIRM Study Group, Ioannis Anastasiou, Fadi Antaki, György Baffy, Divya Bhatt, Kerry Brandt Dunbar, Jill Elwing, Paul Feldman, Ronald Fernando, Deborah A Fisher, Andrew J. Gawron, Jeffrey Gill, Stephan Goebel, Susan F. Goldsmith, Katarina B. Greer, Ildiko Halasz, Minh Q. Ho, Nancy Ho, Samuel B Ho, Mazen Jamal, Charles J Kahi, Andrew M. Kaz, Natalia Khalaf, Margaret Kinnard, Rachel Koppelman, Kyle P. Lehenbauer, John Lieb, Mohammad Madhoun, Priscilla Magno, Ranjan Mascarenhas, Folasade P May, Stacy B. Menees, Andy J Mengshol, Farrukh Merchant, Jed Olson, Endashaw Omer, Dipendra Parajuli, Swati G Patel, Emily Carter Paulson, Marcos Pedrosa, Hugo Pinillos, Joseph R Pisegna, Heiko Pohl, Devang Prajapati, Kittichai Promrat, Petr Protiva, Divyanshoo Rai Kohli, Rajarajeshwari Ramachandran, Adnan Said, Sameer D. Saini, Phillip Schoenfeld, Mitchell Schubert, Tilak Shah, Prateek Sharma, Brian A. Sullivan, Dennis H Sullivan, Edward Sun, Alexander M. Sy, William M. Tierney, Martin Tobi, Claudio Tombazzi, Doris H. Toro, Amelia E. Underwood, Erik C. von Rosenvinge, Helen Wong, Michael Yao, Sonia Yoon |
| Journal | jnci cancer spectrum |
| Year | 2026 |
| DOI |
10.1093/jncics/pkag080
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.